Tesamorelin + Ipamorelin — the GHRH + GHRP body-composition combination researched by high-performance users.
The Hollywood Stack is the body-composition-focused variant of the GH Axis Stack. It pairs Tesamorelin (FDA-approved GHRH analog for HIV-associated lipodystrophy) with Ipamorelin (clean GHRP) to drive a stronger IGF-1 response than either alone.
The combination is researched by high-performance users — athletes, executives, media-facing professionals — pursuing visceral-fat reduction and recomposition. Tesamorelin has the strongest published evidence for visceral adiposity specifically, which is why it anchors this stack.
No compound here is presented as a treatment for any condition except Tesamorelin's on-label indication. Body-composition goals are a conversation with a provider who can rule out the metabolic and hormonal factors that often drive them.
Tesamorelin is a stabilized GHRH analog with the strongest published visceral-fat-reduction data in the GH-peptide class. Ipamorelin is a GHRP (ghrelin-receptor agonist) that provides a clean GH pulse via a different receptor. Pairing the two produces synergistic IGF-1 elevation — the GHRH signal plus the GHRP signal converge on the same pituitary output.
When running a stack like this, these biomarkers let users see how the compounds perform in context. Trended across draws, they reveal whether the stack is actually moving the markers it should — or producing unintended shifts that warrant a provider conversation.
Tesamorelin cycles of 12–26 weeks are common in community reports. Ipamorelin runs alongside. Cycling is a provider conversation.
Body-composition complaints often trace to thyroid, low testosterone, poor sleep, or dietary patterns. A provider should rule these out first — they are higher-leverage than any peptide protocol.
Log every compound in the stack, upload your lab PDFs, and chart the biomarkers on this page across every draw. StackAI reads the panel in context of what you’re running.
Start tracking free →